Literature DB >> 9545707

[Outcome of intensive care].

H P Schuster1.   

Abstract

BACKGROUND: The mean hospital mortality of patients after intensive therapy in Germany is about 15%, the mortality within the intensive care unit about 8%. Short-term prognosis is mainly determined by severity of disease, type of disease and patient age. FACTORS IN INTENSIVE CARE: The impact of disease severity is measured by acute physiology score systems. The significance of disease categories becomes apparent in disease states with a continuing high mortality. Age is an independent risk factor. The higher risk of older patients cannot be explained by different diagnosis, and it is not secondary to a less aggressive therapy. The same factors mainly determine long-term prognosis. The 5-year-survival rate after intensive therapy is around 60%, a 3-fold increase as compared to the general population. Dependent upon the disease category, survival curves of intensive care patients parallel survival curves of the general population 2 years after admission. Analysis of quality of life is based upon objective measurement and subjective estimation of health-related life quality in the physical, psychological, and social life domain. Patients after intensive therapy experience a moderate but significant decrease in quality of life. This is the case in global estimations of quality of life as well as in investigations of different life domains.
CONCLUSION: The remaining quality of life is tolerable. This is in accordance with the positive overall judgement of intensive care by patients themselves. The chief problem of intensive care remain diseases with continuing high mortality.

Entities:  

Mesh:

Year:  1998        PMID: 9545707     DOI: 10.1007/BF03043283

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  36 in total

Review 1.  Post-hospital outcome following intensive care.

Authors:  R Brooks; A Bauman; K Daffurn; K Hillman
Journal:  Clin Intensive Care       Date:  1995

2.  Quality of life among long-term survivors of intensive care.

Authors:  B Zarén; U Hedstrand
Journal:  Crit Care Med       Date:  1987-08       Impact factor: 7.598

3.  Five-year survival after intensive care--comparison of 12,180 patients with the general population. Finnish ICU Study Group.

Authors:  M Niskanen; A Kari; P Halonen
Journal:  Crit Care Med       Date:  1996-12       Impact factor: 7.598

4.  Quality-adjusted life years: origins, measurements, applications, objections.

Authors:  S Schwartz; J Richardson; P P Glasziou
Journal:  Aust J Public Health       Date:  1993-09

5.  Quality of life 6 months after intensive care: results of a prospective multicenter study using a generic health status scale and a satisfaction scale.

Authors:  D Hurel; P Loirat; F Saulnier; F Nicolas; F Brivet
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

6.  One-year outcome of elderly and young patients admitted to intensive care units.

Authors:  K Rockwood; T W Noseworthy; R T Gibney; E Konopad; A Shustack; D Stollery; R Johnston; M Grace
Journal:  Crit Care Med       Date:  1993-05       Impact factor: 7.598

7.  Quality of life and resuscitation decisions in elderly patients.

Authors:  T J Starr; R A Pearlman; R F Uhlmann
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

8.  Outcome from intensive care. II. A 5-year study of 1308 patients: short-term outcome.

Authors:  L Dragsted; J Qvist; M Madsen
Journal:  Eur J Anaesthesiol       Date:  1989-03       Impact factor: 4.330

9.  Intensive care for the elderly: outcome of elective and nonelective admissions.

Authors:  W M Sage; C R Hurst; J F Silverman; W M Bortz
Journal:  J Am Geriatr Soc       Date:  1987-04       Impact factor: 5.562

10.  Quality of life after intensive care with the sickness impact profile.

Authors:  Z M Tian; D R Miranda
Journal:  Intensive Care Med       Date:  1995-05       Impact factor: 17.440

View more
  1 in total

1.  [Value of the Hannover Intensive Score (HIS) in internal medicine intensive care].

Authors:  A von Bierbrauer; C Burchardt; H H Müller; P von Wichert
Journal:  Med Klin (Munich)       Date:  1998-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.